Printer Friendly

EROX CORPORATION FILES WITH SEC FOR PROPOSED PUBLIC OFFERING

 EROX CORPORATION FILES WITH SEC FOR PROPOSED PUBLIC OFFERING
 NEW YORK and MENLO PARK, Calif., Sept. 28 /PRNewswire/ -- EROX Corporation has filed with the Securities and Exchange Commission a registration statement relating to a proposed public offering of up to 1,750,000 shares of common stock. The shares will be offered directly by EROX without use of underwriters or a placement agent.
 The net proceeds of the offering will be used by EROX to purchase inventory, advertising, capital equipment and for product development and working capital.
 EROX is a developing-stage company founded in 1989 to develop and market innovative fine fragrances containing human pheromones for use in perfumes and cosmetic products.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted prior to the time the registration statement becomes effective. This announcement shall not constitute an offer to sell, nor the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The offering of these securities shall only be made by means of a prospectus.
 -0- 9/28/92
 /CONTACT: Pierre de Champfleury, 212-333-8618, or Kevin McCarthy, 415-324-1231, both for EROX/ CO: EROX Corporation ST: California IN: HOU SU: OFR


CK-OS -- NY039 -- 3965 09/28/92 12:22 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 28, 1992
Words:256
Previous Article:DION ENTERTAINMENT STRIKES AGREEMENT WITH BALLY GAMING
Next Article:PLM INTERNATIONAL AGREES TO SETTLEMENT IN DANIELS ACTION
Topics:


Related Articles
EROX FILES REGISTRATION STATEMENT
EROX FILES REGISTRATION STATEMENT WITH SEC
EROX Discloses Results of Scientific Study
EROX Announces First Quarter 1997 Results
/C O R R E C T I O N -- EROX Restates Second Quarter 1997 Results/(Correction Notice)
EROX Corporation Granted Patent Protection in Europe
EROX Corporation Changes Name to Human Pheromone Sciences, Inc.
Human Pheromone Sciences, Inc. Settles Patent Infringement Lawsuit
Human Pheromone Sciences, Inc. Announces Sales Management Restructuring.
Human Pheromone Sciences Appoints Greg Fredrick Vice President, Controller.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters